Icosavax Analyst Ratings
Icosavax Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/02/2023 | 222.58% | Oppenheimer | → $25 | Reiterates | Outperform → Outperform |
| 04/25/2023 | 248.39% | Oppenheimer | → $27 | Reiterates | → Outperform |
| 01/04/2023 | 248.39% | Oppenheimer | → $27 | Initiates Coverage On | → Outperform |
| 08/23/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 08/23/2021 | 545.16% | Evercore ISI Group | → $50 | Initiates Coverage On | → Outperform |
| 08/23/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 08/23/2021 | 545.16% | Jefferies | → $50 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 10/02/2023 | 222.58% | 奧本海默 | →$25 | 重申 | 跑贏→跑贏大盤 |
| 04/25/2023 | 248.39% | 奧本海默 | →$27 | 重申 | →跑贏大盤 |
| 01/04/2023 | 248.39% | 奧本海默 | →$27 | 開始承保 | →跑贏大盤 |
| 2021/08/23 | - | 威廉·布萊爾 | 開始承保 | →跑贏大盤 | |
| 2021/08/23 | 545.16% | Evercore ISI集團 | →$50 | 開始承保 | →跑贏大盤 |
| 2021/08/23 | - | 考恩公司 | 開始承保 | →跑贏大盤 | |
| 2021/08/23 | 545.16% | 傑富瑞 | →$50 | 開始承保 | →購買 |
What is the target price for Icosavax (ICVX)?
ICosavax(ICVX)的目標價是多少？
The latest price target for Icosavax (NASDAQ: ICVX) was reported by Oppenheimer on October 2, 2023. The analyst firm set a price target for $25.00 expecting ICVX to rise to within 12 months (a possible 222.58% upside). 3 analyst firms have reported ratings in the last year.
奧本海默於2023年10月2日報道了ICosavax(納斯達克代碼：ICVX)的最新目標價。這家分析公司將目標價定為25美元，預計洲際交易所將在12個月內上漲(可能上漲222.58%)。3家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Icosavax (ICVX)?
ICosavax(ICVX)的最新分析師評級是多少？
The latest analyst rating for Icosavax (NASDAQ: ICVX) was provided by Oppenheimer, and Icosavax reiterated their outperform rating.
納斯達克(Sequoia Capital：ICVX)的最新分析師評級是由奧本海默提供的，該公司重申了其表現優於大盤的評級。
When is the next analyst rating going to be posted or updated for Icosavax (ICVX)?
ICosavax(ICVX)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Icosavax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Icosavax was filed on October 2, 2023 so you should expect the next rating to be made available sometime around October 2, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公開財務報表，與ICosavax的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。ICosavax的上一次評級是在2023年10月2日提交的，所以你應該預計下一次評級將在2024年10月2日左右的某個時候提供。
Is the Analyst Rating Icosavax (ICVX) correct?
分析師對ICosavax(ICVX)的評級正確嗎？
While ratings are subjective and will change, the latest Icosavax (ICVX) rating was a reiterated with a price target of $0.00 to $25.00. The current price Icosavax (ICVX) is trading at is $7.75, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的ICosavax(ICVX)評級被重申，目標價在0.00美元至25.00美元之間。目前ICosavax(ICVX)的交易價格為7.75美元，在分析師的預測範圍內。